Combined target-based and ligand-based drug design approach as a tool to define a novel 3D-pharmacophore model of human A3 adenosine receptor antagonists: pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as a key study.

Source:http://linkedlifedata.com/resource/pubmed/id/15634009

J. Med. Chem. 2005 Jan 13 48 1 152-62

Download in:

View as

General Info

PMID
15634009